The accompanying cover story summarizes some pioneering activities in collagen cross-linking for keratoconus.
In this commentary, I am going to take a look into the future of CXL and share some of my thoughts. A few may be controversial to some readers. In advance, I will disclose that I consult widely in the field of keratoconus management, including Avellino, CXLO, Glaukos, iVeena, Johnson & Johnson Vision, KeraFlow, Visionary Ventures and Zeiss.
First, the global consensus is that progressive keratoconus should be detected early and treated immediately. I believe that keratoconus is